Blair William & Co. IL Sells 3,603 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Blair William & Co. IL reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 7.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 47,144 shares of the financial services provider’s stock after selling 3,603 shares during the quarter. Blair William & Co. IL’s holdings in iShares Biotechnology ETF were worth $6,471,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Blue Fin Capital Inc. boosted its position in shares of iShares Biotechnology ETF by 0.7% in the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares during the period. Main Street Financial Solutions LLC raised its stake in iShares Biotechnology ETF by 1.0% during the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after purchasing an additional 82 shares during the last quarter. Perkins Coie Trust Co boosted its holdings in iShares Biotechnology ETF by 0.3% in the 2nd quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock valued at $3,457,000 after purchasing an additional 83 shares during the period. HCR Wealth Advisors grew its position in iShares Biotechnology ETF by 0.6% in the 2nd quarter. HCR Wealth Advisors now owns 13,453 shares of the financial services provider’s stock worth $1,847,000 after purchasing an additional 83 shares during the last quarter. Finally, Optimum Investment Advisors increased its holdings in shares of iShares Biotechnology ETF by 2.9% during the 2nd quarter. Optimum Investment Advisors now owns 3,024 shares of the financial services provider’s stock worth $415,000 after purchasing an additional 85 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

IBB stock opened at $147.98 on Friday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57. The business’s 50-day simple moving average is $145.74 and its 200 day simple moving average is $138.54.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.